The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
Open accessAbstract
A potent, synthetic cannabinoid was radiolabeled and used to characterize and precisely localize cannabinoid receptors in slide-mounted sections of rat brain and pituitary. Assay conditions for 3H-CP55,940 binding in Tris-HCl buffer with 5% BSA were optimized, association and dissociation rate constants determined, and the equilibrium dissociation constant (Kd) calculated (21 nM by liquid scintillation counting, 5.2 nM by quantitative autoradiography). The results of competition studies, using several synthetic cannabinoids, add to prior data showing enantioselectivity of binding and correlation of in vitro potencies with potencies in biological assays of cannabinoid actions. Inhibition of binding by guanine nucleotides was selective and profound: Nonhydrolyzable analogs of GTP and GDP inhibited binding by greater than 90%, and GMP and the nonhydrolyzable ATP analog showed no inhibition. Autoradiography showed great heterogeneity of binding in patterns of labeling that closely conform to cytoarchitectural and functional domains. Very dense 3H-CP55,940 binding is localized to the basal ganglia (lateral caudate-putamen, globus pallidus, entopeduncular nucleus, substantia nigra pars reticulata), cerebellar molecular layer, innermost layers of the olfactory bulb, and portions of the hippocampal formation (CA3 and dentate gyrus molecular layer). Moderately dense binding is found throughout the remaining forebrain. Sparse binding characterizes the brain stem and spinal cord. Densitometry confirmed the quantitative heterogeneity of cannabinoid receptors (10 nM 3H-CP55,940 binding ranged in density from 6.3 pmol/mg protein in the substantia nigra pars reticulata to 0.15 pmol/mg protein in the anterior lobe of the pituitary). The results suggest that the presently characterized cannabinoid receptor mediates physiological and behavioral effects of natural and synthetic cannabinoids, because it is strongly coupled to guanine nucleotide regulatory proteins and is discretely localized to cortical, basal ganglia, and cerebellar structures involved with cognition and movement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CB1 receptors are localized to the central nervous system (CNS) and the periphery. CB1 receptors are found in sites associated with pain processing, including the periaqueductal gray (PAG),8 rostral ventromedial medulla (RVM),8 thalamus,9 dorsal root ganglia (DRG),10 amygdala,8 and cortex8.”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
G PROTEINS: TRANSDUCERS OF RECEPTOR-GENERATED SIGNALS
Gilman, A. G. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003151 · Cited by 6,405
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
Self-citationIsolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Self-citationThe organization of the projection from the cerebral cortex to the striatum in the rat
McGeorge, A. J., & Faull, R. L. M. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90128-0 · Cited by 1,360
Baserga, R. (1967) · JAMA · doi:10.1001/jama.1967.03130250093034 · Cited by 1,146
Hypoplasia of cerebellar vermal lobules VI and VII in autism
Courchesne, E., Yeung-Courchesne, R., Hesselink, J. R., & Jernigan, T. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805263182102 · Cited by 1,058
Rogers, A. W. (1967) · Medical Entomology and Zoology · Cited by 1,026
Kelley, A. E., Domesick, V. B., & Nauta, W. J. H. (1982) · Neuroscience · doi:10.1016/0306-4522(82)90067-7 · Cited by 888
Research works printed but not linked: 3
- Harris LS, Dewey WL, Razdan RK (1977) Cannabis. Its chemistry, pharmacology, and toxicology. In: Handbook of experimental phar- macology (Martin WR, ed), pp 37 l-%29. New York: Springer.
- Margulies JE, Hammer RP (1991) THC alters cerebral metabolism in limbic and cortical regions in a biphasic, dose-dependent manner. Ale Drug Res, in press.
- Pertwee RG (1985) Cannabis. In: Psychopharmacology 2, Pt 1: Pre- clinical psychopharmacology (Grahame-Smith DG, Cowan PJ, eds), pp 364-39 1. Amsterdam: Elsevier.
Cited by
Sorted by citations
Items 801–900 of 1,009
Phytocannabinoids and Endocannabinoids
Fišar, Z. (2009) · Current Drug Abuse Reviews · doi:10.2174/1874473710902010051 · Cited by 57
Hoozen, B. E. V., & Cross, C. E. (1997) · Clinical Reviews in Allergy & Immunology · doi:10.1007/bf02737700 · Cited by 56
Onaivi, E. S., Chakrabarti, A. K., & Chaudhuri, G. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(95)00044-5 · Cited by 55
Naderi, N., Ahari, F. A., Shafaghi, B., Najarkolaei, A. H., & Motamedi, F. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0076-x · Cited by 55
An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters
Moise, A. M., Eisenstein, S. A., Astarita, G., Piomelli, D., & Hohmann, A. G. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1209-5 · Cited by 55
Cannabinoid Receptor–Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation
Smith, T. H., Blume, L. C., Straiker, A. J., Cox, J. O., David, B. G., McVoy, J. R. S., Sayers, K. W., Poklis, J. L., Abdullah, R. A., Egertová, M., et al. (2015) · Molecular Pharmacology · doi:10.1124/mol.114.096495 · Cited by 56
Winsauer, P. J., Daniel, J. M., Filipeanu, C. M., Leonard, S. T., Hulst, J. L., Rodgers, S. P., Lassen-Greene, C. L., & Sutton, J. L. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00227.x · Cited by 55
The Endocannabinoid System and Anxiety
Lisboa, S. F. D. S., Gomes, F. V., Terzian, A. L. B., de Aguiar, D. C., Moreira, F. A., Resstel, L. B. M., & Guimarães, F. S. (2016) · Vitamins and hormones · doi:10.1016/bs.vh.2016.09.006 · Cited by 56
Alterations in behavioral flexibility by cannabinoid CB1 receptor agonists and antagonists
Hill, M. N., Froese, L. M., Morrish, A. C., Sun, J. C., & Floresco, S. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0421-4 · Cited by 57
Cannabinoid CB2receptor expression in the rat brainstem cochlear and vestibular nuclei
Baek, J., Zheng, Y., Darlington, C. L., & Smith, P. F. (2008) · Acta Oto-Laryngologica · doi:10.1080/00016480701796944 · Cited by 55
Freiman, I., Anton, A., Monyer, H., Urbanski, M. J., & Szabó, B. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.114272 · Cited by 55
de Miguel, R., Romero, J., Muñoz, R. M., Garcı́a-Gil, L., González, S. R., Villanúa, M. Á., Makriyannis, A., Ramos, J. A., & Fernández‐Ruíz, J. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00185-3 · Cited by 55
Developmental aspects of anandamide: ontogeny of response and prenatal exposure
Fride, E., & Mechoulam, R. (1996) · Psychoneuroendocrinology · doi:10.1016/0306-4530(95)00039-9 · Cited by 55
Lisboa, S. F., Vila-Verde, C., Rosa, J., Uliana, D. L., Stern, C. A. J., Bertoglio, L. J., Resstel, L. B., & Guimaraes, F. S. (2019) · Psychopharmacology · doi:10.1007/s00213-018-5127-x · Cited by 54
Newsom, R. J., Osterlund, C., Masini, C. V., Day, H. E., Spencer, R. L., & Campeau, S. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.043 · Cited by 54
Lisboa, S. F. D. S., & Guimarães, F. S. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.02.008 · Cited by 54
Álvaro-Bartolomé, M., & Garcı́a-Sevilla, J. A. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.05.035 · Cited by 54
Silva, L., Zhao, N., Popp, S., & Dow-Edwards, D. (2011) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2011.10.006 · Cited by 47
Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions
Zlebnik, N. E., & Cheer, J. F. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1712-16.2016 · Cited by 58
Spicing Up Pharmacology: A Review of Synthetic Cannabinoids From Structure to Adverse Events
Davidson, C., Opacka‐Juffry, J., Arévalo‐Martín, Á., García‐Ovejero, D., Molina‐Holgado, E., & Molina‐Holgado, F. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.05.001 · Cited by 55
de Bruin, N. M. W. J., Prickaerts, J., Lange, J. H. M., Akkerman, S., Andriambeloson, E., de Haan, M., Wijnen, J., Drimmelen, M. V., Hissink, E., Heijink, L., et al. (2010) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2010.01.010 · Cited by 54
Endocannabinoid Signaling in Midbrain Dopamine Neurons: More than Physiology?
Melis, M., & Pistis, M. (2007) · Current Neuropharmacology · doi:10.2174/157015907782793612 · Cited by 53
Harte, L. C., & Dow-Edwards, D. (2010) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2010.05.001 · Cited by 51
McLaughlin, R. J., Hill, M. N., & Gorzalka, B. B. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.09.055 · Cited by 53
Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid
Porcella, A., Marchese, G., Casu, M. A., Rocchitta, A., Lai, M., Gessa, G. L., & Pani, L. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1470255 · Cited by 53
Waes, V. V., Tseng, K. Y., & Steiner, H. (2011) · Basal Ganglia · doi:10.1016/j.baga.2011.04.001 · Cited by 53
Canazza, I., Ossato, A., Vincenzi, F., Gregori, A., Rosa, F. D., Nigro, F., Rimessi, A., Pinton, P., Varani, K., Borea, P. A., et al. (2017) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2601 · Cited by 53
Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy
Senn, L., Cannazza, G., & Biagini, G. (2020) · Pharmaceuticals · doi:10.3390/ph13080174 · Cited by 55
Zebra Finch CB1 Cannabinoid Receptor: Pharmacology and in Vivo and in Vitro Effects of Activation
Soderstrom, K., & Johnson, F. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29527-6 · Cited by 53
A review of the safety of selective serotonin reuptake inhibitors during pregnancy
GOLDSTEIN, D. J., & Sundell, K. L. (1999) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199907)14:5 · Cited by 19
Yuan, X.-C., Zhu, B., Jing, X.-H., Xiong, L., Wu, C.-H., Gao, F., Li, H., Xiang, H.-C., Zhu, H., Zhou, B., et al. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00112 · Cited by 52
Dogrul, A. B., Seyrek, M., Yalçın, B., & Ulugöl, A. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.01.007 · Cited by 52
Mishima, K., Egashira, N., Matsumoto, Y., Iwasaki, K., & Fujiwara, M. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02274-9 · Cited by 52
Anderson, L. A., Anderson, J. J., Chase, T. N., & Walters, J. R. (1995) · Brain Research · doi:10.1016/0006-8993(95)00645-7 · Cited by 52
Whitlow, C. T., Freedland, C. S., & Porrino, L. J. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1001-x · Cited by 52
Glucose-Sensing in the Reward System
Koekkoek, L. L., Mul, J. D., & la Fleur, S. E. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00716 · Cited by 51
Linking Mitochondria and Synaptic Transmission: The CB1 Receptor
Djeungoue‐Petga, M., & Hébert-Chatelain, É. (2017) · BioEssays · doi:10.1002/bies.201700126 · Cited by 53
Ahn, D. K., Choi, H. S., Yeo, S. P., Woo, Y. W., Lee, M. K., Yang, G. Y., Jeon, H., Park, J. S., & Mokha, S. S. (2007) · Pain · doi:10.1016/j.pain.2007.01.015 · Cited by 51
A possible role for the endocannabinoid system in the neurobiology of depression
Serra, G., & Fratta, W. (2007) · Clinical Practice and Epidemiology in Mental Health · doi:10.1186/1745-0179-3-25 · Cited by 51
The effect of δ-9-tetrahydrocannabinol on forebrain ischemia in rat
Louw, D. F., Yang, F. W., & Sutherland, G. R. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02422-1 · Cited by 51
La-Vu, M. Q., Sethi, E., Maesta-Pereira, S., Schuette, P. J., Tobias, B. C., Reis, F. M., Wang, W., Torossian, A., Bishop, A., Leonard, S. J., et al. (2022) · eLife · doi:10.7554/elife.77115 · Cited by 50
Almada, R. C., Roncon, C. M., Elias-Filho, D. H., & Coimbra, N. C. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.048 · Cited by 50
Cortical thinness and volume differences associated with marijuana abuse in emerging adults
Mashhoon, Y., Sava, S., Sneider, J. T., Nickerson, L. D. H., & Silveri, M. M. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.06.016 · Cited by 50
Gómez, O., Sanchez-Rodriguez, M. A., Ortega‐Gutiérrez, S., Vázquez‐Villa, H., Guaza, C., Molina‐Holgado, F., & Molina‐Holgado, E. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9609-x · Cited by 50
A CB2-Selective Cannabinoid Suppresses T-Cell Activities and Increases Tregs and IL-10
Robinson, R. H., Meissler, J. J., Fan, X., Yu, D., Adler, M. W., & Eisenstein, T. K. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9611-3 · Cited by 54
�sterlund, M. K., Halldin, C., & Hurd, Y. L. (2000) · Synapse · doi:10.1002/(sici)1098-2396(200001)35:1 · Cited by 108
Electrophysiological effects of a cannabinoid on neural activity in the globus pallidus
Miller, A. S., & Walker, J. M. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00111-2 · Cited by 50
Reduction of Auditory P50 Gating Response in Marihuana Users: Further Supporting Data
Patrick, G., & Struve, F. A. (2000) · Clinical Electroencephalography · doi:10.1177/155005940003100207 · Cited by 50
Bonnin, A., de Miguel, R., Hernández, M., Ramos, J. A., & Fernández‐Ruíz, J. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00205-k · Cited by 50
Differential gene expression in migratory streams of cortical interneurons
Antypa, M., Faux, C., Eichele, G., Parnavelas, J. G., & Andrews, W. D. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07896.x · Cited by 49
Kwee, C., Baas, J. M. P., van der Flier, F. E., Groenink, L., Duits, P., Eikelenboom, M., van der Veen, D. C., Moerbeek, M., Batelaan, N. M., van Balkom, A. J. L. M., et al. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.04.003 · Cited by 50
Lee, T. T. ‐., Wainwright, S. R., Hill, M. N., Galea, L. A. M., & Gorzalka, B. B. (2013) · Hippocampus · doi:10.1002/hipo.22221 · Cited by 56
Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids Signaling
Basavarajappa, B. S. (2015) · Brain Sciences · doi:10.3390/brainsci5040456 · Cited by 48
Pellerito, O., Notaro, A., Sabella, S., Blasio, A. D., Vento, R., Calvaruso, G., & Giuliano, M. (2014) · APOPTOSIS · doi:10.1007/s10495-014-0985-0 · Cited by 49
Hill, M. N., Barr, A. M., Ho, W. ‐. V., Carrier, E. J., Gorzalka, B. B., & Hillard, C. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04688.x · Cited by 49
Picone, R. P., & Kendall, D. A. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1062 · Cited by 49
Perra, S., Pillolla, G., Luchicchi, A., & Pistis, M. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00588.x · Cited by 49
Bassi, M. S., Gilio, L., Maffei, P., Dolcetti, E., Bruno, A., Buttari, F., Centonze, D., & Iezzi, E. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00424 · Cited by 51
Ferreira‐Junior, N. C., Pereira, M. D. S., Guimarães, F. S., & Bel, E. D. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00109-8 · Cited by 53
Role of endocannabinoid system in mental diseases
Manzanares, J., Urigüen, L., Rubio, G., & Palomo, T. (2004) · Neurotoxicity Research · doi:10.1007/bf03033223 · Cited by 49
Cannabinoid CB1 receptor-mediated impairment of visuospatial attention in the rat
Arguello, P. A., & Jentsch, J. D. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1953-0 · Cited by 49
Molina‐Holgado, F., Molina‐Holgado, E., Leret, M. L., Gonz�lez, M. I., & Reader, T. A. (1993) · Neurochemical Research · doi:10.1007/bf00978372 · Cited by 49
Baskfield, C. Y., Martin, B. R., & Wiley, J. L. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.055376 · Cited by 49
Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells
Bernal‐Chico, A., Tepavčević, V., Manterola, A., Utrilla, C. L., Matute, C., & Mato, S. (2022) · Glia · doi:10.1002/glia.24172 · Cited by 50
Hill, M. N., Hunter, R. G., & McEwen, B. S. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.04.048 · Cited by 48
Sommer, C., Schomacher, M., Berger, C., Kuhnert, K., Müller, H. D., Schwab, S., & Schäbitz, W. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0110-8 · Cited by 48
Horne, E. A., Coy, J. W., Swinney, K., Fung, S., Cherry, A. E., Marrs, W., Naydenov, A. V., Lin, Y. H., Sun, X., Keene, C. D., et al. (2012) · European Journal of Neuroscience · doi:10.1111/ejn.12045 · Cited by 49
Protein Interactors and Trafficking Pathways That Regulate the Cannabinoid Type 1 Receptor (CB1R)
Fletcher-Jones, A., Hildick, K. L., Evans, A. J., Nakamura, Y., Henley, J. M., & Wilkinson, K. A. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00108 · Cited by 54
Combination of Rimonabant and Donepezil Prolongs Spatial Memory Duration
Wise, L. E., Iredale, P. A., Stokes, R. J., & Lichtman, A. H. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301297 · Cited by 48
Garcı́a-Arencibia, M., García, C., Kurz, A., Rodríguez‐Navarro, J. A., Gispert-Sánchez, S., Mena, M. A., Auburger, G. W. J., de Yébenes, J. G., & Fernández‐Ruíz, J. (2009) · Springer eBooks · doi:10.1007/978-3-211-92660-4_22 · Cited by 48
The effects of acute treatment with Δ9-THC on exploratory behaviour and memory in the rat
Hernández‐Tristán, R., Arévalo, C., Canals, S., & Leret, M. L. (2000) · Journal of Physiology and Biochemistry · doi:10.1007/bf03179772 · Cited by 48
Steffens, M., Szabó, B., Klar, M., Rominger, A., Zentner, J., & Feuerstein, T. J. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00318-x · Cited by 48
Freedland, C. S., Whitlow, C. T., Miller, M. D., & Porrino, L. J. (2002) · Synapse · doi:10.1002/syn.10089 · Cited by 48
Cannabimimetic Activity in Rats and Pigeons of HU 210, a Potent Antiemetic Drug
Ferrari, F., Ottani, A., & Giuliani, D. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00114-2 · Cited by 48
Wang, S., Lim, G., Mao, J., Sung, B., Yang, L., & Mao, J. (2007) · Pain · doi:10.1016/j.pain.2006.12.019 · Cited by 46
Cannabinoids Biology: The Search for New Therapeutic Targets
Felder, C. C. (2006) · Molecular Interventions · doi:10.1124/mi.6.3.6 · Cited by 47
Castelli, M. P., Piras, A. P., Melis, T., Succu, S., Sanna, F., Melis, M., Collu, S., Ennas, M. G., Diaz, G., Mackie, K., et al. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.02.062 · Cited by 47
Hrubá, L., Ginsburg, B. C., & McMahon, L. R. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.196444 · Cited by 47
ORTIZ, S. (2004) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh063 · Cited by 47
Edwards, A., & Abizaid, A. B. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.032 · Cited by 54
Cannabinoids as therapeutics for PTSD
Sbarski, B., & Akirav, I. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107551 · Cited by 47
The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Δ9-tetrahydrocannabinol
Verty, A. N. A., McGregor, I. S., & Mallet, P. E. (2004) · Brain Research · doi:10.1016/j.brainres.2004.06.033 · Cited by 47
Differential Regulation of Behavioral Tolerance to WIN55,212-2 by GASP1
Martini, L., Thompson, D., Kharazia, V., & Whistler, J. L. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.6 · Cited by 47
Breivogel, C. S., Walker, J. M., Huang, S. M., Roy, M. B., & Childers, S. R. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.02.017 · Cited by 47
Zhou, D., & Shearman, L. P. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.10.015 · Cited by 51
Tersigni, T. J., & Rosenberg, H. C. (1996) · Brain Research · doi:10.1016/0006-8993(96)00533-1 · Cited by 47
Abboussi, O., Tazi, A., Païzanis, E., & Ganouni, S. E. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.02.014 · Cited by 47
Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids
Appiah‐Kusi, E., Leyden, E., Parmar, S. R., Mondelli, V., McGuire, P. K., & Bhattacharyya, S. (2015) · Psychological Medicine · doi:10.1017/s0033291715001786 · Cited by 46
Lopes, J. B., Bastos, J. D. R., Briânis, R. C., de Aguiar, D. C., & Moreira, F. A. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05370-5 · Cited by 46
Garcı́a-Gil, L., de Miguel, R., Romero, J., Merchán-Pérez, Á., Ramos, J. A., & Fernández‐Ruíz, J. (1999) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(98)00058-0 · Cited by 46
Castelli, M. P., Piras, A. P., D'Agostino, A., Pibiri, F., Perra, S., Gessa, G. L., Maccarrone, M., & Pistis, M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.06.047 · Cited by 46
Proudnikov, D., Kroslak, T., Sipe, J. C., Randesi, M., Li, D., Hamon, S., Ho, A., Ott, J., & Kreek, M. J. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.59 · Cited by 46
Cannabinoids in neurodegeneration and neuroprotection
Fernández‐Ruíz, J., González, S. R., Romero, J., & Ramos, J. A. (2005) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7358-x_5 · Cited by 46
Hill, M. N., & Gorzalka, B. B. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.11.010 · Cited by 49
Rubino, T., Viganò, D., Costa, B., Colleoni, M., & Parolaro, D. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752478.x · Cited by 46
Walker, J. M., Strangman, N. M., & Huang, S. M. (2001) · Pain Research and Management · doi:10.1155/2001/413641 · Cited by 46
Basavarajappa, B. S., & Hungund, B. L. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1094 · Cited by 46
Williams, J., Haller, V. L., Stevens, D. L., & Welch, S. P. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.12.035 · Cited by 45
Bouskila, J., Burke, M., Zabouri, N., Casanova, C., Ptito, M., & Bouchard, J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.041 · Cited by 45
Pellerito, O., Calvaruso, G., Portanova, P., BLASIO, A. D., Santulli, A., Vento, R., Tesoriere, G., & Giuliano, M. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.062257 · Cited by 45
Metadata
- Authors
- Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Herkenham, M
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 1991-02-01
- Volume
- 11
- Issue
- 2
- Pages
- 563-583
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6575215
- OpenAlex
- W1836729582
- Cited by
- 2,159
- References
- 65
- Citations by year
- 2026: 23 · 2025: 23 · 2024: 43 · 2023: 56 · 2022: 64 · 2021: 65 · 2020: 84 · 2019: 61 · 2018: 74 · 2017: 70 · 2016: 70 · 2015: 95 · 2014: 77 · 2013: 74 · 2012: 86
- FWCI
- 14.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- cannabinoid receptors, receptor localization, receptor density, G protein coupling, enantioselectivity, basal ganglia, cerebellar molecular layer, olfactory bulb, hippocampus, substantia nigra pars reticulata, pituitary gland, rat brain
- MeSH terms
- Animals, Autoradiography, Brain, Buffers, Cannabinoids, Cyclohexanols, Male, Rats, Inbred Strains, Receptors, Drug, Serum Albumin, Bovine, Temperature, Time Factors, Tissue Distribution, Receptors, Cannabinoid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review